A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
A Phase 3, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Rheumatoid Arthritis
The purpose of this study is to investigate the long-term safety and any side effects of baricitinib in participants who have completed a previous baricitinib rheumatoid arthritis study.
The study provides 7 years of additional treatment with baricitinib.
Inclusion Criteria:
Exclusion Criteria:
Asheville, North Carolina 28803, United States
Charlotte, North Carolina 28207, United States
Ciudad Autonoma de Buenos Aire, Buenos Aires C1426AAL, Argentina
CABA, Ciudad Autonoma Buenos Aires C1125ABD, Argentina
CABA, Ciudad Autonoma de Buenos Aire 1204, Argentina
SAN M. de Tucuman, Tucumán Province T4000AXL, Argentina
San Miguel de Tucumán, Tucumán Province T4000BRD, Argentina
Ciudad Autonoma Buenos Aires, C1425AGC, Argentina
Ciudad Autonoma de Buenos Aire, C1015ABO, Argentina
Ciudad Autonoma de Buenos Aire, C1128AAF, Argentina
Ciudad Autonoma de Buenos Aire, C1221ADC, Argentina
Ciudad Autonoma de Buenos Aire, C1417EYG, Argentina
Ciudad Autonoma de Buenos Aire, C1428DZF, Argentina
Ciudad Autonoma de Buenos Aire, C1430CKE, Argentina
Ciudad Autonoma de Buenos Aire, C1431FWO, Argentina
Ciudad Autonoma de Buenos Aire, C1440AAD, Argentina
Saint Catherines, Ontario L2N 7E4, Canada
Budapest, Pest County 1027, Hungary
Nyíregyháza, Szabolcs-Szatmár-Bereg 4400, Hungary
Hyderabad, Andhra Pradesh 500072, India
Chuo-ku, Chiba 260-8712, Japan
Hakata-ku, Fukuoka 812-0025, Japan
Kita-gun, Kagawa-ken 761-0793, Japan
Arakawa-ku, Tokyo 116-8567, Japan
Chuo-Ku, Tokyo 104 8560, Japan
Itabashi-ku, Tokyo 173-8610, Japan
Meguro-Ku, Tokyo 152-8902, Japan
Shinjuku-Ku, Tokyo 160-8582, Japan
Bydgoszcz, 85-168, Poland
Tg.Mures, Mureș County 540136, Romania
Saint-Petersburg, Leningradskaya Oblast' 194291, Russia
Neihu Taipei, 11490, Taiwan